Item 16. FORM 10-K SUMMARY
19K characters. Original on sec.gov · Markdown
Item 16. FORM 10-K SUMMARY
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, West Pharmaceutical Services, Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
WEST PHARMACEUTICAL SERVICES, INC.
(Registrant)
By: /s/ William J. Federici
William J. Federici
Senior Vice President and Chief Financial Officer
February 26, 2018
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of West Pharmaceutical Services, Inc. in the capacities and on the dates indicated.
| Signature | Title | Date |
| /s/ Eric M. Green | Director, President and Chief Executive Officer | February 26, 2018 |
| Eric M. Green | (Principal Executive Officer) | |
| /s/ Daniel Malone | Vice President and Controller | February 26, 2018 |
| Daniel Malone | (Principal Accounting Officer) | |
| /s/ William J. Federici | Senior Vice President and Chief Financial Officer | February 26, 2018 |
| William J. Federici | (Principal Financial Officer) | |
| /s/ Mark A. Buthman | Director | February 13, 2018 |
| Mark A. Buthman | ||
| /s/ William F. Feehery, Ph.D. | Director | February 13, 2018 |
| William F. Feehery, Ph.D. | ||
| /s/ Thomas W. Hofmann | Director | February 13, 2018 |
| Thomas W. Hofmann | ||
| /s/ Paula A. Johnson, M.D., MPH | Director | February 13, 2018 |
| Paula A. Johnson, M.D., MPH | ||
| /s/ Deborah L.V. Keller | Director | February 13, 2018 |
| Deborah L.V. Keller | ||
| /s/ Myla P. Lai-Goldman, M.D. | Director | February 13, 2018 |
| Myla P. Lai-Goldman, M.D. | ||
| /s/ Douglas A. Michels | Director | February 13, 2018 |
| Douglas A. Michels | ||
| /s/ Paolo Pucci | Director | February 13, 2018 |
| Paolo Pucci | ||
| /s/ John H. Weiland | Director | February 13, 2018 |
| John H. Weiland | ||
| /s/ Patrick J. Zenner | Director and Chairman of the Board | February 13, 2018 |
| Patrick J. Zenner |
EXHIBIT INDEX
F-1
F-2
| (1) | We agree to furnish to the SEC, upon request, a copy of each instrument with respect to issuances of long-term debt of the Company and its subsidiaries. |
| (2) | Management compensatory plan. |
| (3) | Certain portions of this exhibit have been omitted and filed separately with the SEC pursuant to a confidential treatment order of the SEC. |
| (4) | Certain portions of this exhibit have been omitted pursuant to a confidential treatment request submitted to the SEC. |
| * | Furnished, not filed. |
F-3
Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details